StockNews.AI
TVTX
StockNews.AI
117 days

Travere Therapeutics to Report First Quarter 2025 Financial Results

1. TVTX to report Q1 2025 earnings on May 1, 2025. 2. A conference call will follow the earnings report for updates.

Earnings
+3.97%Current Return
VS
+0.73%S&P 500
$17.6304/24 04:42 PM EDTEvent Start
$18.3304/25 10:58 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

Earnings announcements typically lead to volatility, but no significant changes are indicated previously. Comparatively, similar announcements have historically resulted in slight price movements unless expectations are exceeded or missed.

How important is it?

Earnings reports can directly affect stock prices; however, without further context, the impact is uncertain. Investors often look for growth indicators in reports, which may influence their decisions on TVTX.

Why Short Term?

The immediate market reaction is expected around the earnings report date. Historical precedents show that short-term impacts often coincide with earnings reports.

Related Companies

NASDAQ: TVTXNASDAQ: AMGNNASDAQ: RARE
SAN DIEGO--(BUSINESS WIRE)-- #1Q25Earnings--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2025 financial results on Thursday, May 1, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere's website at https://ir.travere.com/events-and-presentations. Fo.

Related News